Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Fabre-Kramer Pharmaceuticals
Indiana Republican Congresswoman Jackie Walorski, who died in a car crash Wednesday, was a strong proponent of device industry priorities such as device tax repeal and Medicare coverage for innovative technologies.
China reports flu outbreaks as COVID-19 cases decline, suggesting that population immunity may have been affected by the country's strict "COVID Zero" policies. The cost and availability of flu vaccines in the country are other policy factors playing into the situation.
Panel expects to review five respiratory syncytial virus vaccines and vote on one or two of them in June 2023 and others four months later. Sanofi presents results of three clinical trials of its monoclonal antibody nirsevimab, which is on track to be the second RSV prophylaxis for infants.
The approval is the 25th indication for the diagnostic, but the first for any companion diagnostic to Roche’s Rozlytrek.
- Specialty Pharmaceuticals
- Controlled Release